RYTM Operating Cash Flow (Statement)

Rhythm Pharmaceuticals Inc · Operating Cash Flow (Statement)

RYTM logo

RYTM Operating Cash Flow (Statement)

Latest reported-$149.53M
RYTM TTM Cash from Operations (-$7.51M → -$149.53M)
High-resolution chart · PNG

RYTM operating cash flow (statement) history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Rhythm Pharmaceuticals Inc Operating Cash Flow (Statement) — Trailing twelve months (TTM) (USD)
Period endingOperating Cash Flow (Statement) (USD)
-149,533,000
-119,509,000
-115,675,000
-109,131,000
-107,724,000
-113,487,000
-113,879,000
-124,417,000
-128,453,000
-140,467,000
-136,157,000
-140,774,000
-158,510,000
-156,229,000
-173,428,000
-179,900,000
-173,073,000
-166,104,000
-146,003,000
-134,654,000
-121,524,000
-119,413,000
-121,980,000
-125,078,000
-131,653,000
-127,470,000
-122,750,000
-111,512,000
-94,849,000
-81,783,000
-62,056,000
-48,958,000
-40,433,000
-34,095,000
-29,460,000
-27,754,000
-23,780,000
-23,848,000
-23,219,000
-20,701,000
-17,848,000
-12,501,000
-6,977,000
-4,082,000
-3,677,000
-5,592,500
-7,508,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.